Quantumzyme Corp. (QTZM)

Quantumzyme Cash Flow Statement

Financials in millions USD. Fiscal year is August - July.

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Oct 31, 2025	Jul 31, 2025	Jul 31, 2024
Net Income	-0.18	-0.2	-0.18
Other Operating Activities	-0	-0	-
Change in Accounts Payable	0.08	0.07	0.08
Change in Other Net Operating Assets	-0	0.01	-0
Operating Cash Flow	-0.11	-0.13	-0.1
Short-Term Debt Issued	-	0.08	0.1
Total Debt Issued	0.07	0.08	0.1
Net Debt Issued (Repaid)	0.07	0.08	0.1
Issuance of Common Stock	0.04	0.04	-
Financing Cash Flow	0.11	0.13	0.1
Net Cash Flow	-0	0	-
Levered Free Cash Flow	-	-0.05	-
Unlevered Free Cash Flow	-	-0.04	-
Change in Working Capital	0.08	0.08	0.08

Source: S&P Global Market Intelligence. Standard template. Financial Sources.